 CENTOGENE CNTG, a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, and the Cologne-based blockchain start-up Ubirch today announced a joint solution for the successful fight against the effects of SARS-CoV-2 the virus causing COVID-19 on the economy and social life in Germany. In the future, SARS-CoV-2 test results will be stored on the blockchain and can be retrieved at any time serving as a virtual certificate of immunity to the virus. The current contact restrictions in Germany cannot be upheld until a Coronavirus vaccine is ready for market, which has major consequences on the economy and the ability for individuals to move about freely. 